However, this trend was not observed in the findings of Uprimny et al. While PSMA PET/CT generally correlates with higher Gleason scores, poorly differentiated tumors might alter PSMA expression due to changes in tumor biology or microenvironment. This evidence concerns the gene FOLH1 and neoplasm.